Gilman Louie

Gilman Louie is the Chief Executive Officer of LookingGlass. In this role, he provides guidance, direction, and vision to help the company meet its mission, support its customers, and exceed growth goals.

Mr. Louie was the first CEO of In-Q-Tel, an independent, non-profit venture capital firm established with the backing of the Central Intelligence Agency. He served in that role from 1999 to 2006. Under Mr. Louie’s leadership, In-Q-Tel invested in and worked with more than 80 companies that have had a significant impact on national security. Some of these companies include Arcsight, Keyhole (now Google Earth), Palantir, Language Weaver, Endeca, and Decru.

Previous to In-Q-Tel, Gilman built a career as a pioneer in the interactive entertainment industry, with accomplishments that include the design and development of the Falcon F-16 flight simulator, as well as the licensing of Tetris, the world’s most popular computer game, from its developers in the Soviet Union.

He has served as a member of the Technical Advisory Group of the United States Senate Select Committee on Intelligence, and as a Commissioner of the National Commission for Review of Research and Development Programs of the United States Intelligence Community. He is a former member of the board of the CIA Officer’s Memorial Foundation, has received the CIA’s Director’s Award, and in 2002 was names as one of fifty scientific visionaries by Scientific American.

Mr. Louie is also a special government employee (SGE) to the Defense Innovation Board where he co-authored the 5G Report and the Software Acquisition and Practices Study. In addition, he serves as a commissioner on National Security Commission on Artificial Intelligence. He is also Co-Founder and Partner of Alsop Louie Partners, an early-stage technology venture capital firm founded in 2006 and located in San Francisco. The firm focuses on disruptive and innovative technologies and has made investments in the areas of cybersecurity, predictive analytics, education, and entertainment.